Joslin Diabetes Center, Inc.
For 110 years, Joslin Diabetes Center has been internationally recognized for its leadership in diabetes research, patient care and training. An affiliate of Harvard Medical School, Joslin is the world’s largest institution dedicated exclusively to diabetes, and is unique in its commitment to both patient care and research. The Elliott P. Joslin Research Laboratory includes 11 laboratory sections dedicated to research in basic and clinical studies matching the range of diabetes causes and complications. Joslin’s research staff and the clinical staff of its multi-specialty medical practice, the Joslin Clinic, together include internationally recognized scientists from multiple disciplines, providing an unparalleled range of research, treatment and education for people with diabetes. More information on Joslin’s research activities can be found at www.joslinresearch.org. More complete descriptions of these inventions can be found at – Joslin Diabetes Center, Inc
Innovations (57):
- Melanocyte Concentrating Hormone Knockout Mice (09 MAR 09)
- Encapsulated Pancreatic Cell Islet Products (09 MAR 09)
- Methods of Generating Insulin-Producing Cells (09 MAR 09)
- Methods and Compositions for Inducing Brown Adipogenesis (09 MAR 09)
- Improving Glycemic Control (09 MAR 09)
- Diagnosing and Treating Retinal Vascular Permeability (09 MAR 09)
- Compositions and Methods for Treating Diabetic Eye Disease (09 MAR 09)
- ARNT2: A Novel Target for Diabetes (09 MAR 09)
- Treatment of Cardiovascular Disorders with Salicylates (09 MAR 09)
- Methods for Treatment of Rheumatoid Arthritis (09 MAR 09)
Find more innovations
